LV12271B - COMBINED VACCINE FOR CHILDREN WITH HIGHLY VACCINE COMPONENT IMUNOGENIC ACTIVITY - Google Patents
COMBINED VACCINE FOR CHILDREN WITH HIGHLY VACCINE COMPONENT IMUNOGENIC ACTIVITY Download PDFInfo
- Publication number
- LV12271B LV12271B LVP-99-29A LV990029A LV12271B LV 12271 B LV12271 B LV 12271B LV 990029 A LV990029 A LV 990029A LV 12271 B LV12271 B LV 12271B
- Authority
- LV
- Latvia
- Prior art keywords
- vaccine
- antigen
- diphtheria
- tetanus
- pertussis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96699592A | 1992-10-27 | 1992-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
LV12271A LV12271A (lv) | 1999-05-20 |
LV12271B true LV12271B (en) | 1999-07-20 |
Family
ID=25512167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-99-29A LV12271B (en) | 1992-10-27 | 1999-02-22 | COMBINED VACCINE FOR CHILDREN WITH HIGHLY VACCINE COMPONENT IMUNOGENIC ACTIVITY |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0594950B1 (es) |
JP (1) | JPH07300427A (es) |
KR (1) | KR100289224B1 (es) |
AT (1) | ATE176157T1 (es) |
AU (1) | AU669570B2 (es) |
CA (1) | CA2109159A1 (es) |
CZ (1) | CZ283587B6 (es) |
DE (2) | DE69323264D1 (es) |
DK (1) | DK0594950T3 (es) |
ES (1) | ES2126616T3 (es) |
FI (1) | FI934725A (es) |
GR (1) | GR3029884T3 (es) |
HK (1) | HK1009931A1 (es) |
HU (1) | HU215149B (es) |
IL (1) | IL107387A (es) |
LV (1) | LV12271B (es) |
NO (1) | NO308588B1 (es) |
NZ (1) | NZ250029A (es) |
PL (1) | PL174130B1 (es) |
RU (1) | RU2121365C1 (es) |
SG (1) | SG47725A1 (es) |
TW (1) | TW256774B (es) |
UA (1) | UA27754C2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5725860A (en) * | 1994-03-07 | 1998-03-10 | Auckland Uniservices Limited | Method for reducing the risk of developing diabetes |
WO1996040242A1 (en) * | 1995-06-07 | 1996-12-19 | Smithkline Beecham Biologicals S.A. | Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
US20020054884A1 (en) | 1995-06-23 | 2002-05-09 | Smithkline Beecham Biologicals, Sa | Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
ATE433329T1 (de) * | 1995-06-23 | 2009-06-15 | Glaxosmithkline Biolog Sa | Impfstoff bestehend aus auf aluminium-phosphat adsorbiertem, konjugiertem polysaccharid antigen |
AU714493B2 (en) * | 1996-07-02 | 2000-01-06 | Connaught Laboratories Limited | Multivalent DTP-polio vaccines |
UA85853C2 (uk) * | 2000-06-29 | 2009-03-10 | Глаксосмітклайн Байолоджікалз С.А. | Полівалентна імуногенна композиція |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
AU2003278166B2 (en) | 2002-11-01 | 2009-01-29 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
GB0505996D0 (en) * | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
CN103083657B (zh) | 2005-06-27 | 2016-06-08 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902506A (en) * | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
-
1993
- 1993-07-22 DK DK93111735T patent/DK0594950T3/da active
- 1993-07-22 EP EP93111735A patent/EP0594950B1/en not_active Expired - Lifetime
- 1993-07-22 ES ES93111735T patent/ES2126616T3/es not_active Expired - Lifetime
- 1993-07-22 SG SG1996004072A patent/SG47725A1/en unknown
- 1993-07-22 DE DE69323264A patent/DE69323264D1/de not_active Expired - Fee Related
- 1993-07-22 AT AT93111735T patent/ATE176157T1/de not_active IP Right Cessation
- 1993-07-22 DE DE69323264T patent/DE69323264T4/de not_active Expired - Lifetime
- 1993-08-10 TW TW082106371A patent/TW256774B/zh active
- 1993-10-21 JP JP5285570A patent/JPH07300427A/ja active Pending
- 1993-10-22 NZ NZ250029A patent/NZ250029A/en unknown
- 1993-10-22 RU RU93048161A patent/RU2121365C1/ru active
- 1993-10-25 IL IL107387A patent/IL107387A/xx not_active IP Right Cessation
- 1993-10-25 CA CA002109159A patent/CA2109159A1/en not_active Abandoned
- 1993-10-26 FI FI934725A patent/FI934725A/fi unknown
- 1993-10-26 NO NO933856A patent/NO308588B1/no not_active IP Right Cessation
- 1993-10-26 PL PL93300859A patent/PL174130B1/pl unknown
- 1993-10-26 HU HU9303028A patent/HU215149B/hu not_active IP Right Cessation
- 1993-10-26 CZ CZ932272A patent/CZ283587B6/cs not_active IP Right Cessation
- 1993-10-26 AU AU50290/93A patent/AU669570B2/en not_active Ceased
- 1993-10-26 KR KR1019930022374A patent/KR100289224B1/ko not_active IP Right Cessation
- 1993-10-27 UA UA93003281A patent/UA27754C2/uk unknown
-
1998
- 1998-09-14 HK HK98110626A patent/HK1009931A1/xx not_active IP Right Cessation
-
1999
- 1999-02-22 LV LVP-99-29A patent/LV12271B/en unknown
- 1999-04-05 GR GR990400973T patent/GR3029884T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH07300427A (ja) | 1995-11-14 |
HK1009931A1 (en) | 1999-06-11 |
EP0594950A1 (en) | 1994-05-04 |
HU215149B (hu) | 2000-03-28 |
HU9303028D0 (en) | 1994-01-28 |
NZ250029A (en) | 1994-09-27 |
NO933856D0 (no) | 1993-10-26 |
RU2121365C1 (ru) | 1998-11-10 |
DK0594950T3 (da) | 1999-09-13 |
FI934725A (fi) | 1994-04-28 |
NO933856L (no) | 1994-04-28 |
NO308588B1 (no) | 2000-10-02 |
EP0594950B1 (en) | 1999-01-27 |
HUT67239A (en) | 1995-03-28 |
PL174130B1 (pl) | 1998-06-30 |
IL107387A0 (en) | 1994-01-25 |
CZ283587B6 (cs) | 1998-05-13 |
IL107387A (en) | 1997-04-15 |
DE69323264D1 (de) | 1999-03-11 |
FI934725A0 (fi) | 1993-10-26 |
KR940008698A (ko) | 1994-05-16 |
TW256774B (es) | 1995-09-11 |
UA27754C2 (uk) | 2000-10-16 |
CZ227293A3 (en) | 1994-05-18 |
AU669570B2 (en) | 1996-06-13 |
DE69323264T4 (de) | 1999-10-14 |
AU5029093A (en) | 1994-05-12 |
CA2109159A1 (en) | 1994-04-28 |
GR3029884T3 (en) | 1999-07-30 |
SG47725A1 (en) | 1998-04-17 |
ES2126616T3 (es) | 1999-04-01 |
ATE176157T1 (de) | 1999-02-15 |
KR100289224B1 (ko) | 2001-05-02 |
DE69323264T2 (de) | 1999-06-02 |
LV12271A (lv) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5637848B2 (ja) | 髄膜炎ワクチンの製剤化 | |
JP4871770B2 (ja) | 組み合わせ髄膜炎ワクチン | |
US6329512B1 (en) | Immunogenic conjugate molecules | |
TWI286938B (en) | Immunogenic compositions comprising polysaccharide conjugate antigens and protein D from haemophilus influenzae, methods of preparing the same and vaccines comprising the same | |
RU2444374C2 (ru) | Получение вакцин, содержащих поверхностный антиген вируса гепатита в и поверхностно-активное вещество | |
Weinberg et al. | Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein conjugate vaccine | |
RU2420315C2 (ru) | Комбинированные вакцины с антигеном коклюша цельных клеток | |
JP2010529103A5 (es) | ||
SK283565B6 (sk) | Multivalentná imunogénna kompozícia a jej použitie | |
US9040058B2 (en) | Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use | |
EP2661277A2 (en) | A combination heptavalent vaccine | |
Alexander et al. | Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE®) | |
JP2012506420A (ja) | 全細胞百日咳を含む混合ワクチン | |
EP0594950B1 (en) | Combination pediatric vaccine with enhanced immunogenicity of each vaccine component | |
Redhead et al. | Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity | |
EP2592137A1 (en) | Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use | |
AU2013203663B2 (en) | Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use | |
Schedule et al. | Supplementary Table 1: Trials included in Hib conjugate vaccine review, detailed information | |
Gross | 2 Combination Vaccines | |
PL174077B1 (pl) | Szczepionka do ochrony przed zakażeniem lub leczeniem zakażeń Hepatitis B i heterologicznych chorób, zawierająca antygen powierzchniowy Hepatitis B (HBsAg) | |
GB2498112A (en) | Preparation of a diphtheria toxoid by incubating toxin concentrate with an amino acid and formaldehyde |